Ποια είναι η κεφαλαιοποίηση αγοράς για Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534)

Η κεφαλαιοποίηση αγοράς για Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534) είναι $661.58M

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534) Τιμή και Κεφαλαιοποίηση Αγοράς

Q: Ποια είναι η τιμή για Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534)

Η τιμή για Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534) είναι $2.18

Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd operates as a pharmaceutical enterprise, focusing on the research, development, manufacturing, and commercialization of traditional Chinese medicines, health supplements, and active pharmaceutical ingredients (APIs). Its extensive product line includes therapeutic remedies such as Yuanhu Analgesic dropping pills, Qiwei Wenyang capsules, Maxing cough capsules, Shuxinning tablets, Panax notoginseng pills, Anti-inflammatory and gallbladder tablets, Children's Qingfei cough tablets, Pediatric Qinggan tablets, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, Astragalus Angelica capsules, and berberine tannin films. Beyond its core manufacturing, the company is actively involved in the cultivation, procurement, processing, and distribution of Chinese medicinal raw materials. Its operations further encompass project investment and management, alongside the import, sale, logistics, and export of pharmaceutical goods. Established in 2002, Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd is headquartered in Lanzhou, China.

Η τιμή για 300534	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$17,352.74 $661.58M	NVDA	$5.264T	+795,549.17%
$15,498.12 $661.58M	AAPL	$4.701T	+710,511.76%
$13,770.39 $661.58M	GOOG	$4.177T	+631,292.77%
$12,584.35 $661.58M	MSFT	$3.817T	+576,911.47%
$9,449.10 $661.58M	AMZN	$2.866T	+433,155.29%

Η τιμή για 300534

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$17,352.74 $661.58M